Edwards Lifesciences Corporation Share Price Berne S.E.
Equities
001065343
US28176E1082
Advanced Medical Equipment & Technology
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
83.18 CHF | +1.86% |
|
-.--% | +20.95% |
Sales 2024 * | 6.56B 5.84B 517B | Sales 2025 * | 7.2B 6.41B 568B | Capitalization | 52.83B 47B 4,166B |
---|---|---|---|---|---|
Net income 2024 * | 1.61B 1.43B 127B | Net income 2025 * | 1.86B 1.66B 147B | EV / Sales 2024 * | 7.8 x |
Net cash position 2024 * | 1.67B 1.49B 132B | Net cash position 2025 * | 2.8B 2.49B 221B | EV / Sales 2025 * | 6.94 x |
P/E ratio 2024 * |
33
x | P/E ratio 2025 * |
28.3
x | Employees | 19,800 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 91.59% |
Latest transcript on Edwards Lifesciences Corporation
1 day | +1.86% | ||
3 months | +2.67% | ||
6 months | +20.95% | ||
Current year | +20.95% |
![Extreme 61.716](/images/extremecours_fleche.png)
![Extreme 61.716](/images/extremecours_fleche.png)
![Extreme 61.716](/images/extremecours_fleche.png)
![Extreme 60.6](/images/extremecours_fleche.png)
![Extreme 24.9333](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 56 | 31/12/14 | |
Scott Ullem
DFI | Director of Finance/CFO | 57 | 31/12/13 |
Todd Brinton
CTO | Chief Tech/Sci/R&D Officer | - | 31/01/19 |
Members of the board | Title | Age | Since |
---|---|---|---|
Leslie Heisz
BRD | Director/Board Member | 63 | 04/07/16 |
Chairman | 67 | 12/11/14 | |
Steven Loranger
BRD | Director/Board Member | 72 | 15/03/16 |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.16% | 189B | |
+26.21% | 150B | |
+32.78% | 113B | |
+1.98% | 65.05B | |
+2.92% | 49.39B | |
-6.60% | 38.1B | |
-1.07% | 35.14B | |
+23.08% | 31.2B | |
+18.25% | 24.35B |
- Stock Market
- Equities
- EW Stock
- 001065343 Stock